PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 24, 2025BMC Psychiatry0 citationsOpen Access

Efficacy and safety profile of vortioxetine as an add-on molecule in obsessive-compulsive disorder: a randomized double-blinded placebo-controlled superiority trial – a study protocol

View Full Paper
SMSucharita MandalAGAparajita GuinPMPrasenjit Mitra

Key Points

Key points are not available for this paper at this time.

Abstract

The trial was registered with the Clinical Trials Registry - India (CTRI) (registration ID: CTRI/2023/12/060748) on December 26, 2023.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mandal et al. (2025) studied this question.

synapsesocial.com/papers/69403b822d562116f290bf9ahttps://doi.org/10.1186/s12888-025-07374-2
Ask AI
Helpful
Bookmark
Share
View Full Paper